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Abstract
Background: Whether low-intensity radiofrequency radiation damages the blood-brain barrier
has long been debated, but little or no consideration has been given to the blood-cerebrospinal
fluid barrier. In this cross-sectional study we tested whether long-term and/or short-term use of
wireless telephones was associated with changes in the serum transthyretin level, indicating altered
transthyretin concentration in the cerebrospinal fluid, possibly reflecting an effect of radiation.
Methods: One thousand subjects, 500 of each sex aged 18–65 years, were randomly recruited
using the population registry. Data on wireless telephone use were assessed by a postal
questionnaire and blood samples were analyzed for serum transthyretin concentrations
determined by standard immunonephelometric techniques on a BN Prospec® instrument.
Results: The response rate was 31.4%. Logistic regression of dichotomized TTR serum levels with
a cut-point of 0.31 g/l on wireless telephone use yielded increased odds ratios that were statistically
not significant. Linear regression of time since first use overall and on the day that blood was
withdrawn gave different results for males and females: for men significantly higher serum
concentrations of TTR were seen the longer an analogue telephone or a mobile and cordless
desktop telephone combined had been used, and in contrast, significantly lower serum levels were
seen the longer an UMTS telephone had been used. Adjustment for fractions of use of the different
telephone types did not modify the effect for cumulative use or years since first use for mobile
telephone and DECT, combined. For women, linear regression gave a significant association for
short-term use of mobile and cordless telephones combined, indicating that the sooner blood was
withdrawn after the most recent telephone call, the higher the expected transthyretin
concentration.
Conclusion:  In this hypothesis-generating descriptive study time since first use of mobile
telephones and DECT combined was significantly associated with higher TTR levels regardless of
how much each telephone type had been used. Regarding short-term use, significantly higher TTR
concentrations were seen in women the sooner blood was withdrawn after the most recent
telephone call on that day.
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Background
The use of wireless telephones has reached one hundred
percent prevalence in many countries. Studies on the
potentially harmful biological effects of the radiofre-
quency fields (RF) emanating from these devices are thus
pertinent. Dysfunction of the blood-brain barrier (BBB) is
one such effect that has long been debated (for reviews,
see Nittby et al. [1] and Orendacova et al. [2]). A barrier
that has received much less attention, though it also serves
to maintain brain homeostasis by separating the central
nervous system from the blood stream, is the so-called
blood-cerebrospinal fluid barrier (BCSFB). These brain
barriers should be given equal importance as both are
implicated in chronic neurodegenerative brain diseases
[3]. While the BBB separates or controls the traffic of mol-
ecules from the blood to the cerebral interstitial fluid, the
BCSFB is a discontinuity in the circulation between the
blood and cerebrospinal fluid (CSF). The former is made
of endothelial cells and the latter of epithelial cells. A leak-
age or an alteration in the turnover of brain-derived pro-
teins may be used to evaluate the integrity of these
barriers, possibly reflecting an effect of RF.
We previously reported on a possible association between
serum concentrations of the calcium-binding protein
S100B and self-reported use of wireless telephones among
healthy Swedish adults [4]. Mainly synthesized by the
end-feet of astrocytes, S100B has been described as a suit-
able marker of integrity of the BBB [5-8]. In the present
paper, using the same data, we report the results of analy-
sis of serum levels of transthyretin (TTR), a key CSF pro-
tein. TTR could potentially serve as marker of BCSFB
dysfunction.
TTR, also known as prealbumin, is a plasma and CSF car-
rier of thyroxin and retinol and is also described as seques-
tering amyloid beta peptide in the brain [9]. Its major sites
of synthesis are the liver, the choroid plexus (CP) and the
retinal pigment epithelium. TTR is used in clinical practice
as a marker in several conditions, such as predicting out-
come for critically ill patients [10], in Alzheimer's disease
[11,12], amyloidosis [13], inflammation and malnutri-
tion [14].
With regard to synthesis in the brain, TTR, unlike S100B,
is not expressed by perivascular astrocytes [15]. It is
mainly produced by the epithelial cells of the CP located
in the four ventricles, representing about 25% of the CSF
protein [16]. CP expands to fill nearly all the cerebral ven-
tricles and has brush-type borders, microvilli, on the api-
cal side. Once filtered by these brushes of microvilli, the
CSF flows from the lateral ventricles through the third and
fourth ventricles to the subarachnoid space. From there
the fluid spreads over the entire surfaces of the brain and
spinal cord.
Most of the CSF is emptied into the blood in the venous
sinuses by way of arachnoid granulations. These protru-
sions are particularly abundant in the superior sagital
sinuses. The passage of CSF into the venous sinuses is
caused by hydrostatic pressure, which is higher in the sub-
arachnoid space, about 15 cm H2O, than in the sinuses,
7–8 cm H2O [17]. Concentrations of TTR in healthy
adults have been reported to be in the range 0.017–0.025
g/L in the CSF [18-20] and 0.20–0.40 g/L in the plasma
[21].
Several features make the BCSFB and TTR secretion by the
CP particularly interesting for studying a possible effect of
RF. Firstly, owing to the enlarged area of microvilli, the CP
has a total surface within the same order of magnitude as
the BBB [22]. Secondly, it has a rapid blood supply, about
10-fold faster than other regions of the brain [23], with
extremely fenestrated endothelial cells that are also quite
leaky [24]. Thus, large molecules can readily pass into the
connective tissue, but are prevented from further entering
the CSF by the tight junctions between epithelial cells.
Thirdly, however, these junctions in the BCSFB are leakier
than those between the endothelial cells of the BBB
[25,26], which would increase the likelihood of insult to
the choroidal tissue by toxic materials originating from
the blood. Finally, the CP, especially in the lateral ventri-
cles, may be associated with the effects of neurotoxic
agents owing to its anatomical location close to several
brain structures, among them the hippocampus.
In the present report we tested whether long-term and/or
short-term use of wireless telephones was associated with
changed concentrations of TTR in the serum as a marker
of alterations in CSF TTR, possibly reflecting an effect of
RF.
Methods
Data collection
One thousand subjects, 500 of each sex, aged 18–65 years
and living in the municipality of Örebro in Sweden, were
randomly recruited using the population registry. They
received a letter of information and were asked to give
informed consent to leave blood and have it stored in a
so-called Biobank. Respondents who chose to take part
then received further information about the purpose of
the study. They were asked to complete a postal question-
naire that covered different topics such as background
characteristics including employment history, use of wire-
less telephones (mobile telephones (analogue NMT, dig-
ital GSM, UMTS) and DECT), various other exposures
such as X-rays, chemicals or radiation therapy and finally
health- and lifestyle-related questions such as physical
exercise and diseases. The first invitations were sent out in
March 2007 and data collection was completed by the end
of November 2007. A more detailed description of theEnvironmental Health 2009, 8:19 http://www.ehjournal.net/content/8/1/19
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study design was presented in the publication about
S100B based on the same data [4]. The study was
approved by the regional ethical vetting board of Uppsala
University.
Analytical methods
Participants were asked if possible to leave blood samples
at Örebro University Hospital in the afternoon at the end
of a working week. All samples were taken by a nurse at
the chemical laboratory after which they were centrifuged
and the supernatant decanted and frozen immediately.
Serum TTR concentrations were determined by standard
immunonephelometric techniques using commercially-
available reagents from Dade Behring GmbH (Marburg,
Germany) on a BN Prospec® instrument (Siemens Health-
care Diagnostics). The total coefficients of variation were
3.4% and 5.5% at concentrations of 0.13 and 0.28 g/L
respectively. All results are expressed in g/L.
Statistical Analysis
Frequency tables were produced and explanatory factors
were analyzed by the Wilcoxon rank-sum test for one-way
comparisons. In all tests the significance level was set at
0.05. Following log-transformation of TTR values to nor-
malize the distribution, linear regression was used to test
an association between long- or short-term trends in wire-
less telephone use and serum concentrations of TTR.
Standardized β coefficients are used throughout.
Short-term use of wireless telephones and serum concen-
trations of TTR were examined by comparing use on the
day the blood sample was left; long-term use by compar-
ing cumulative use and years since start of use, as well as
fractions of total duration for the different telephone
types. To avoid multicollinearity, the fraction of digital
phone, which was the most frequently used, was omitted
in the linear analysis of long-term use.
The Kruskal-Wallis test was used to analyze the frequen-
cies of use in calls per day and the Wilcoxon rank-sum test
to analyze usage in minutes (min) per day. Unconditional
logistic regression was used to calculate odds ratios (OR)
and 95% confidence intervals (CI) for exposed vs. unex-
posed in relation to elevated serum levels of TTR. As far as
we are aware there is no established cut-off for determin-
ing 'normal' and 'elevated' levels of TTR in current use in
clinical practice. We therefore chose the third quartile as
cut-off (0.31 g/L serum) so that a sufficient number (n) of
subjects would be included in the group with 'elevated'
concentrations. Because of the low number of users who
were literally unexposed (n = 3), definitions of exposed
and unexposed in the logistic regression differed depend-
ing on the endpoint of interest. The 'unexposed' in the
analysis of serum TTR and short-term use were those who
reported not having used any type of wireless telephone
on the day the blood was drawn; the 'unexposed' in the
analyses of long-term use were those with non-use and the
quartile with the lowest overall use of mobile telephones
and DECT (≤446 hours). All analyses were done using
StataSE 10.1 (Stata/SE 10.1 for Windows; StataCorp, Col-
lege Station Texas, USA).
Results
Descriptive analysis
One thousand persons were invited to take part in the
study and 314 participated by answering the question-
naire and giving blood. TTR data were missing for one
subject so the final analysis included 313 persons.
Descriptive analysis showed that women were more likely
than men to participate (probability (p) = 0.001; χ2-test)
and that the mean age was higher among participants
than non-participants (p = 0.0001; t-test) (Table 1).
Age and gender predicted TTR levels whereas time, day or
month of drawing blood did not (Table 2). Men had
higher concentrations than women and participants >47
years age had higher serum levels than younger ones,
though when stratification was done on gender a signifi-
cant difference only remained for women (p = 0.02; p =
0.72 for men). Among the explanatory factors assessed by
the self-administered questionnaire hypertension, body
mass index (BMI), smoking and use of oral snuff were all
statistically significantly related to TTR concentrations,
though they had little or no effect when adjusted for in the
analyses. Use of detergents was of borderline significance
(p = 0.049) in women but was based on only 5 subjects,
so no adjustment was made for this variable. Occupation,
workload, head or neck X-ray, external radiation, physical
activity, and various disease conditions did not predict
serum TTR. In further linear and regression analysis, age
was adjusted for in all analyses while adjustment for sex
was applied only in analyses of total samples.
Serum transthyretin levels and use of wireless telephones
Logistic regression analysis of serum TTR and long-term
total use of wireless telephones yielded OR = 1.2, CI = 0.6
– 2.4 (Table 3). Analysis of years since first use of overall
use of wireless telephones for periods of more than 5 and
10 years both yielded statistically insignificant results; OR
= 1.2, CI = 0.6–2.5 and OR = 1.5, CI = 0.7–3.1, respec-
tively. For mobile telephones the highest OR was found
among those who reported > 10 years since first use,
whereas OR for DECT did not change with time since first
use. Also, higher ORs were found for men than for
women.
The linear regression analysis of cumulative hours of use
gave a somewhat lower p-value for the analogue tele-
phone type (p = 0.07) than for other telephone types
(Table 4). Significantly positive β coefficients were foundEnvironmental Health 2009, 8:19 http://www.ehjournal.net/content/8/1/19
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for time since first use of analogue telephones (p = 0.01)
and for mobile telephones and DECT combined (p =
0.03). Stratification on gender gave significant findings
for men and use of mobile telephones (p = 0.04), ana-
logue telephones (p = 0.045) and mobile telephones and
DECT combined (p = 0.04), but not for women. Stratifica-
tion on gender for time since first use of UMTS, on the
other hand, gave statistically significant associations in
the opposite direction; that is, a significant negative β
coefficient (p = 0.02) for men and a significant positive β
coefficient (p = 0.047) for women.
Additional analyses with adjustments for fraction of use
of the different telephone types did not change the overall
results in the linear regression on cumulative hours of use
and time since first use. No statistically significant result
was seen for mobile telephones and DECT for cumulative
use, combined (p = 0.12; data not in table), while for time
since first use a significantly positive β coefficient was
found (p = 0.03; data not in table). Stratification on gen-
der gave similar findings, though for men no longer statis-
tically significant (p = 0.08; data not in table). The results
of fraction analyses showed that neither of the different
types of wireless telephones altered the relative level of
trend for cumulative use or time since first use, totally.
However, for women a higher fraction of UMTS use raised
the level both for cumulative use and time since first use
(p = 0.02; 0.01 respectively; data not in table).
Further analysis yielded a statistically significant differ-
ence for serum TTR concentrations in relation to different
frequencies of use in calls per day for digital (GSM) tele-
phones (p = 0.01; Kruskal-Wallis test) but not for any of
the other telephone types (data not shown). Stratification
on gender gave no significant difference, however (p =
0.12 for men, p = 0.57 for women).
Participants reporting ≤ 15 min average long-term total
use per day were compared with those reporting > 15 min
per day (Wilcoxon rank-sum test). Here we found a statis-
tically significant difference in TTR concentrations for dig-
ital telephones (p = 0.01, higher TTR for >15 min) and
DECT (p = 0.002, lower TTR for >15 min). Again, the sig-
nificances disappeared once stratification was done on
gender (data not shown). However, for men, there was a
tendency towards higher TTR concentrations for those
who reported use of a digital telephone > 15 min per day
(p = 0.06).
Logistic regression analysis of serum TTR and short-term
use of wireless telephones (i.e. same day as leaving blood)
yielded statistically insignificant results (Table 5). In the
Table 1: Descriptive data for the study
Men Women Total
Total included 500 500 1 000
-Age: mean, median 41.8, 41.0 41.6, 42.0 41.7, 42.0
Range 18–65 18–65 18–65
Declined to participate 127 156 283
Did not answer inquiry 196 116 312
Answered yes to participation 177 228 405
-Did not give blood 44 44 88
Participated 133 184 317
-Did not answer the questionnaire 0 2 2
-Unknown date for drawing blood 0 1 1
-Missing data, transthyretin 0 1 1
Final participants 133 180 313
-Age: mean, median 47.1, 50.0 44.4, 46.0 45.6, 47.0
Range 18–65 18–64 18–65Environmental Health 2009, 8:19 http://www.ehjournal.net/content/8/1/19
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linear regression analysis of use of wireless telephones on
the same day as giving blood, mobile telephones and
DECT combined gave a low p-value with a negative β coef-
ficient for time since most recent use (p = 0.06; Table 6),
and this was significant for mobile telephone use by
women (p = 0.03).
Discussion
There is a need to study the possible physiological effects
of RF that might relate to increased risk of chronic disease
in humans. Because most of the near-field RF exposure
emanating from a wireless telephone is absorbed in the
head of the person using the device [27], the brain is one
of the main organs of interest to study. In this cross-sec-
tional study we investigated the possible association
between self-reported use of wireless telephones and
serum TTR concentrations as a marker of alterations in
CSF TTR, possibly reflecting an effect of RF.
Logistic regression analyses of long-term use yielded sta-
tistically insignificant results, though most ORs increased
with years since first use. Linear regression analysis, on the
other hand, gave significant findings for time since first
use both for analogue telephones and for mobile tele-
phones and DECT combined, which after stratification on
gender only remained for men. Gender-specific analyses
also gave statistically significant associations for time
since first use of UMTS, but with β coefficients going in
opposite directions: for men, TTR concentrations
decreased significantly with increasing years, whereas for
women the concentrations increased. What stands out in
this group is that it consisted of significantly younger per-
sons than the participants as a whole, see Table 1 (median
age for men = 41.0 vs. 50.0; for women = 35.5 vs. 46.0).
However, it is the result for men, the negative β coefficient
that deviates from the general trend. Adjusting the gender-
specific analysis for age, hypertension, BMI, smoking and
intake of oral snuff did not change the results. Possibly the
Table 2: Descriptive data for serum transthyretin (g/L)
n Mean Median Min Max p
Transthyretin, total 313 0.277 0.270 0.170 0.480 -
Age (cut-point at median)
≤ 47 years 158 0.271 0.260 0.170 0.480 0.02
> 47 years 155 0.284 0.280 0.180 0.470
Gender
Men 133 0.307 0.300 0.180 0.480 <0.0001
Women 180 0.256 0.250 0.170 0.400
Time (hour) when blood was drawn
06:00–12:00 65 0.286 0.270 0.170 0.420 0.12
12:01–16:00 248 0.275 0.270 0.170 0.480
Day when blood was drawn
Mon-Thur 174 0.276 0.260 0.170 0.440 0.77
Fri-Sun 139 0.279 0.270 0.170 0.480
Month when blood was drawn
March-June 228 0.278 0.270 0.170 0.480 0.94
July-October 85 0.277 0.270 0.170 0.400
The Wilcoxon rank-sum was used to calculate p-values.Environmental Health 2009, 8:19 http://www.ehjournal.net/content/8/1/19
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Table 3: Logistic regression analysis for serum transthyretin and long-term use of wireless telephones
Group Total > 5 years since first use > 10 years since first use
H/La OR 95% CI H/La OR 95% CI H/La OR 95% CI
-Mobile telephones + DECT 56/177 1.2 0.6 – 2.4 56/170 1.2 0.6 – 2.5 40/80 1.5 0.7 – 3.1
-Men 46/58 1.5 0.6 – 3.5 46/57 1.5 0.6 – 3.6 34/39 1.6 0.6 – 3.9
-Women 10/119 0.8 0.3 – 2.6 10/113 0.8 0.3 – 2.7 6/41 1.3 0.4 – 4.6
-Mobile telephones 55/176 1.2 0.6 – 2.4 53/152 1.2 0.6 – 2.5 35/58 1.5 0.7 – 3.3
-Men 45/58 1.4 0.6 – 3.5 45/53 1.6 0.7 – 3.8 32/34 1.7 0.7 – 4.2
-Women 10/118 0.8 0.3 – 2.6 8/99 0.8 0.2 – 2.5 3/24 1.2 0.3 – 5.8
-Analogue 19/33 1.4 0.6 – 3.4 19/32 1.5 0.6 – 3.6 18/29 1.4 0.6 – 3.6
-Men 17/25 1.2 0.5 – 3.3 17/25 1.2 0.5 – 3.3 17/23 1.4 0.5 – 3.7
-Women 2/8 2.4 0.4 – 15 2/7 3.2 0.5 – 22 1/6 2.0 0.2 – 22
-Digital 55/173 1.2 0.6 – 2.5 53/150 1.3 0.6 – 2.6 32/52 1.6 0.7 – 3.6
-Men 45/56 1.5 0.6 – 3.6 45/52 1.6 0.7 – 3.9 29/29 1.8 0.7 – 4.6
-Women 10/117 0.8 0.3 – 2.6 8/98 0.8 0.2 – 2.5 3/23 1.3 0.3 – 6.0
-UMTS 13/30 1.0 0.4 – 2.9 0/0 - - 0/0 - -
-Men 13/17 1.6 0.5 – 5.0 0/0 - - 0/0 - -
-Women 0/13 - - 0/0 - - 0/0 - -
-DECT 54/165 1.3 0.6 – 2.6 44/127 1.3 0.7 – 2.7 17/46 1.3 0.6 – 3.1
-Men 44/51 1.6 0.7 – 3.9 35/38 1.6 0.7 – 4.1 13/17 1.4 0.5 – 4.0
-Women 10/114 0.9 0.3 – 2.7 9/89 0.9 0.3 – 3.0 4/29 1.2 0.3 – 4.9
aH: Transthyretin > 0.31 g/L; L: Transthyretin ≤ 0.31 g/L.
Age was adjusted for in all analyses while adjustment for sex was applied only in analyses of total samples. 'Unexposed' were those with non-use and 
the quartile with the lowest overall use of mobile telephones and DECT (≤446 hours). Persons with missing information about use of wireless 
telephones were excluded from the analysis.Environmental Health 2009, 8:19 http://www.ehjournal.net/content/8/1/19
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Table 4: Linear regression analysis of serum transthyretin and long-term use of wireless telephones
Group n Standardized β coefficient 95% CI p
Cumulative use (hours), mobile telephone/DECT
-Mobile telephones + DECT 308 0.08 -0.02 to 0.18 0.11
-Men 132 0.10 -0.07 to 0.28 0.24
-Women 176 0.09 -0.06 to 0.23 0.25
-Mobile telephones 305 0.08 -0.02 to 0.19 0.11
-Men 131 0.16 -0.02 to 0.33 0.08
-Women 174 -0.02 -0.17 to 0.13 0.80
-Analogue 58 0.24 -0.02 to 0.50 0.07
-Men 45 0.26 -0.05 to 0.56 0.10
-Women 13 0.17 -0.53 to 0.87 0.61
-Digital 302 0.08 -0.02 to 0.18 0.13
-Men 130 0.15 -0.03 to 0.32 0.10
-Women 172 -0.01 -0.16 to 0.14 0.85
-UMTS 49 -0.11 -0.38 to 0.15 0.41
-Men 31 -0.18 -0.54 to 0.17 0.31
-Women 18 0.32 -0.29 to 0.92 0.28
-DECT 279 0.04 -0.07 to 0.14 0.50
-Men 117 -0.13 -0.31 to 0.06 0.17
-Women 162 0.10 -0.05 to 0.25 0.18
Years since first use, mobile telephone/DECT
Mobile telephones + DECT 309 0.13 0.02 to 0.24 0.03Environmental Health 2009, 8:19 http://www.ehjournal.net/content/8/1/19
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maximum time of four years since first use is too short,
and that in combination with the low numbers makes the
analysis sensitive to single deviant values. In women, for
example, one subject with a high TTR concentration con-
tributed strongly to the significantly positive β coefficient
(included = 0.48; excluded = 0.20), and when this value
was omitted the significance disappeared (p = 0.49).
There was no such obvious outlier for men, so the associ-
ation is either real or more likely confounded by some
unknown factor possibly associated with age (median
UMTS = 41 years, mobile telephones and DECT combined
= 50, analogue telephones = 54).
Regarding the analysis of long-term average digital tele-
phone use, higher TTR concentrations were found for
those who reported > 15 min per day. When we stratified
on gender these significances disappeared, but there was
still a tendency towards higher concentrations in men.
-Men 133 0.19 0.01 to 0.38 0.04
-Women 176 0.10 -0.05 to 0.25 0.20
-Mobile telephones 306 0.09 -0.03 to 0.20 0.13
-Men 132 0.20 0.01 to 0.38 0.04
-Women 174 0.01 -0.14 to 0.16 0.90
-Analogue 59 0.34 0.07 to 0.61 0.01
-Men 46 0.33 0.01 to 0.64 0.045
-Women 13 0.48 -0.18 to 1.14 0.14
-Digital 302 0.06 -0.05 to 0.17 0.29
-Men 130 0.14 -0.05 to 0.33 0.14
- Women 172 0.03 -0.12 to 0.17 0.74
-UMTS 49 -0.04 -0.30 to 0.23 0.78
-Men 31 -0.38 -0.71 to -0.06 0.02
-Women 18 0.48 0.01 to 0.94 0.047
-DECT 279 0.05 -0.05 to 0.16 0.33
-Men 117 0.02 -0.17 to 0.20 0.85
-Women 162 0.09 -0.07 to 0.24 0.26
Age was adjusted for in all analyses while adjustment for sex was applied only in analyses of total samples.
Data for cumulative use of mobile telephone/DECT are missing for two persons (one had used only a mobile telephone, the other had used both a 
mobile telephone and DECT). Data for latency of mobile telephone/DECT are missing for one person (a user of both mobile telephone and DECT).
Table 4: Linear regression analysis of serum transthyretin and long-term use of wireless telephones (Continued)Environmental Health 2009, 8:19 http://www.ehjournal.net/content/8/1/19
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The corresponding results for use of DECT, however,
showed significantly decreased concentrations of TTR in
the group who reported > 15 min use per day. That signif-
icance also disappeared when men and women were ana-
lyzed separately. The result was most probably explained
by the fact that the group who used DECT > 15 min per
day was dominated by women (81 out of 117), who had
lower TTR concentrations than men in general.
Analysis of short-term use of mobile telephone and DECT
combined (min since last call) yielded a negative β coeffi-
cient, significantly so for women, indicating that the
sooner blood was withdrawn after the most recent tele-
phone call, the higher the expected TTR concentration.
Since TTR has a biological half-life of 48 hours [20] it
should be a reliable marker of a short-term effect. By that
we mean that its rate of metabolism would not obviate the
possibility of detecting an effect.
Thus, we have somewhat intriguing results for long-term
use of mobile telephones (years since first use), found
only in men, and short-term use (the same day as giving
blood), found only in women. Regarding long-term use,
the differences between men and women might (except
for UMTS) be explained by the fact that men had higher
TTR concentrations than women in general, which was
significantly associated with time since first use. A weak
short-term effect might thus be obscured.
The results might also have been influenced by confound-
ing. The stratified analyses of the different telephone types
could be a problem because of the consecutive marketing
of these devices. Most users of the analogue telephone
later switched to digital (GSM) and UMTS; this overlap
could introduce confounding. Therefore, we also per-
formed the additional analysis with adjustment for frac-
tions of use of the different telephone types, which did
not modify the effect for cumulative use or years since first
use for mobile telephone and DECT, combined. Taking
into account the fraction of each telephone did not alter
the level of the overall trend either, except for women
where the fraction of UMTS use raised the overall trend.
However, also here, the significance disappeared when
the outlier previously mentioned was omitted: for cumu-
lative use p = 0.10; for latency p = 0.08. Thus, while the
results of the separate analyses of different telephone
types might be subject to confounding, this does not affect
the statistically significant result for years since first use for
all types, combined.
The rationale for stratifying the analyses on different gen-
eration telephones, to begin with, was that they might
vary significantly in what modulation and output power
they use, or used. The analogue telephone especially, uses
a higher output level and lacks the adaptive power control
of the more recent telephones. It also uses a lower fre-
quency for transmission than e.g. the GSM when operat-
ing at 1800 MHz and the UMTS at 1900 MHz, which
affects the specific absorption rate (SAR) – distribution in
the head; the lower the frequency the deeper the penetra-
tion of radiation energy. In Sweden, the analogue system
(NMT; Nordic Mobile Telephone System) was closed
down in the end of 2007 after use since 1981; NMT 450
MHz 1981–2007, NMT 900 MHz 1986 – 2000. Of course,
many other factors contribute to variations in the SAR-dis-
tribution of a wireless telephone, not the least how one
positions the phone at the head. Also, with respect to the
more recent telephone with large differences in design,
probably no typical exposure exists for sub-regions of the
brain, like the CP that expands throughout the ventricle
system. What can be said about the exposure in these
deeper parts of the brain is that it is non-thermal, and
probably, in the range of 0.01–0.001 W/kg [28], but
might be higher in CP of the fourth ventricle as the cere-
bellum is one of the brain structures that is exposed the
most [27].
Intake of hormonal drugs, especially by women, was not
assessed in this study and could also have introduced con-
founding. Estrogen use is common among the elderly and
estrogens have been reported to up-regulate TTR synthesis
Table 5: Logistic regression analysis of serum transthyretin and 
short-term use of wireless telephones
Group H/La OR 95% CI
Mobile telephones + DECT 55/156 1.4 0.7 – 2.8
-Men 47/55 1.8 0.8 – 4.3
-Women 8/101 0.9 0.3 – 2.8
-Mobile telephones 46/117 1.5 0.7 – 3.0
-Men 42/43 2.1 0.9 – 5.1
-Women 4/74 0.6 0.2 – 2.3
-DECT 20/79 1.2 0.5 – 2.5
-Men 15/26 1.2 0.5 – 3.3
-Women 5/53 1.0 0.3 – 3.6
aH: Transthyretin > 0.31 g/L; L: Transthyretin ≤ 0.31 g/L.
Age was adjusted for in all analyses while adjustment for sex was 
applied only in analyses of total samples.Environmental Health 2009, 8:19 http://www.ehjournal.net/content/8/1/19
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Table 6: Linear regression analysis of serum transthyretin and short-term use of wireless telephones
Group n Standardized β coefficient 95% CI p
Minutes of use on the day of giving blood
Mobile telephones 163 0.01 -0.13 to 0.14 0.94
-Men 85 0.001 -0.22 to 0.22 0.99
-Women 78 0.03 -0.20 to 0.25 0.82
DECT 99 -0.03 -0.21 to 0.15 0.72
-Men 41 0.01 -0.32 to 0.34 0.97
-Women 58 -0.07 -0.33 to 0.19 0.59
Minutes from last use – blood sampling
Mobile telephones + DECT 205 -0.11 -0.23 to 0.01 0.06
-Men 98 -0.07 -0.27 to 0.14 0.51
-Women 107 -0.21 -0.40 to -0.02 0.03
-Mobile telephones 159 -0.08 -0.21 to 0.06 0.25
-Men 82 0.04 -0.18 to 0.26 0.72
-Women 77 -0.25 -0.47 to -0.03 0.03
-DECT 97 -0.12 -0.30 to 0.06 0.20
-Men 40 -0.14 -0.47 to 0.19 0.40
-Women 57 -0.13 -0.39 to 0.13 0.33
Age was adjusted for in all analyses while adjustment for sex was applied only in analyses of total samples.
Data for minutes from last use of mobile telephone/DECT to blood sampling are missing for six persons (four had used a mobile telephone, two 
had used DECT).Environmental Health 2009, 8:19 http://www.ehjournal.net/content/8/1/19
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in CP and liver in mice [29,30]. Elevated levels of TTR
have also been reported in women using hormonal con-
traceptive drugs [31].
Nutritional status is another source of possible confound-
ing, which was not assessed in this study. Most of the TTR
in the blood is produced by the liver and is regulated inde-
pendently of production by the CP. TTR from the liver is
a marker of malnutrition and inflammatory processes
[20]. However, our study comprised healthy population-
based subjects so it is rather unlikely that malnutrition
influenced the results significantly. Moreover, for hormo-
nal contraceptives and nutritional status – or any other
factor – to confound the results, those factors would have
to covary with wireless telephone use (or start of use).
To avoid potential confounding by gender-associated fac-
tors, stratified analyses adjusted for age were performed
throughout. Because the results were not changed, no
additional adjustment was made for hypertension, BMI,
smoking or use of oral snuff, even though they were statis-
tically significantly related to TTR concentrations. Interest-
ingly, we found higher concentrations of TTR in subjects
who had ever smoked or used oral snuff. As nicotine has
been reported to up-regulate the synthesis and secretion
of TTR in the CP [32], these results support our choice of
method using serum TTR as a marker of TTR in CSF. More-
over, a study on rats showed that nicotine did not up-reg-
ulate synthesis of TTR in the liver, only in CP [33].
Another shortcoming of our study could be that the serum
TTR concentration is expected to be 10-fold higher than
the CSF level. Nevertheless, the highly vascularised CP
and the CSF turnover of four times per 24 hours [23],
together with the 13 times faster synthetic rate of TTR in
CP than in liver [34], would make alterations of TTR in the
CSF detectable in the serum. If we assume that these alter-
ations were caused by RF exposure, there are at least a cou-
ple of potential mechanisms. One is up-regulation of the
TTR gene in epithelial cells; the other is dysfunction of the
BCSFB leading to increased leakage or turnover of TTR in
either the CP and/or the superior sagital sinuses due to the
higher pressure in the subarachnoid space [17].
Ideally, TTR should be analyzed in both CSF and serum.
For ethical reasons this is obviously not possible unless an
opportunity is provided by patients undergoing CSF anal-
ysis for medical purposes. Another possibility would be
proteomics to distinguish TTR from CP and CSF. Alterna-
tively, use of the ratios between TTR and albumin, TTR
and retinol binding protein, and TTR and thyroxin in the
blood could be used to determine the origin of the TTR.
We are now considering how these alternatives may be
explored in further studies along with additional markers
of BCSFB dysfunction.
The initial aim of the present study was to analyze serum
S100B levels as a marker of BBB dysfunction and use of
wireless telephones. The more general shortcomings
related to weaknesses in exposure assessment, study
design and low response rate have been discussed more in
detail in our previous publication [4]. Briefly, use of wire-
less telephones was self-reported and not validated by
operator records; exposure misclassification would thus
be expected to some extent, although this error is unlikely
to have been different with respect to serum TTR concen-
tration since exposure was assessed beforehand. There-
fore, misclassification would most likely be random,
leading to a weaker association – given that there is an
association. While it is a strength that the study was pop-
ulation-based, the low response rate of 31.4% makes the
findings less valid for generalization to the whole popula-
tion. Possibly it also reduces the power of the study.
Conclusion
In conclusion, the main results of this hypothesis-generat-
ing descriptive study were that time since first use of
mobile telephones and DECT combined was significantly
associated with higher TTR levels regardless of how much
each telephone type had been used. With regard to short-
term use significantly higher TTR concentrations were
seen in women the sooner blood was withdrawn after the
most recent telephone call on that day.
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